ETOP IBCSG Partners Foundation

As of July 1, 2021, the two highly respected clinical and translational cancer research foundations ETOP (European Thoracic Oncology Platform) and IBCSG (International Breast Cancer Study Group) have merged to form the joint entity ETOP IBCSG Partners Foundation. The new foundation brings together two strong and equal partners. By joining forces, the position as an international academic research organization is further strengthened www.etop.ibcsg.org.

World’s leading experts are engaged in our research, 36'000 patients that have participated in ETOP IBCSG Partners Foundation breast trials so far.

ETOP IBCSG Partners Foundation receives project-oriented and structural grants from Swiss, American and other non-profit foundations and grant givers. ETOP IBCSG Partners Foundation also collaborates with pharmaceutical companies with guaranteed academic independence. This collaboration allows us to generate funding for participating sites and thus enhances our ability to enroll patients into academic clinical trials.

Personal contributions are also essential to sustain the work of ETOP IBCSG Partners Foundation.

Annual Reports incl. Annual Financial Statement:

2022 ETOP IBCSG Partners Annual Report incl. Annual Financial Statement (E)

2021 ETOP IBCSG Partners Jahresbericht inkl. Jahresrechnung (D)

2022 ETOP IBCSG Partners Annual Report incl. Annual Financial Statement (E)